XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Condensed Statements of Operations and Comprehensive (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenues $ 71,831 $ 49,895 $ 189,781 $ 147,586
Cost of goods sold 72,935 54,680 194,184 152,333
Gross profit (loss) (1,104) (4,785) (4,403) (4,747)
Research and development expenses 52 22 139 66
Selling, general and administrative expenses 6,867 5,087 21,234 16,222
Other operating (income) (428) 0 (68) 0
Operating loss (7,595) (9,894) (25,708) (21,035)
Interest expense        
Interest rate expense 5,456 4,408 14,819 14,902
Debt related fees and amortization expense 1,633 1,140 5,199 3,045
Accretion and other expenses of Series A preferred units 2,774 2,185 5,920 7,928
Loss (gain) on debt extinguishment 49,386 0 49,386 (1,134)
Gain on litigation 0 0 (1,400) 0
Other (income) expense (2) (30) (14,297) 483
Loss before income taxes (66,842) (17,597) (85,335) (46,259)
Income tax expense 3 0 13 7
Net loss (66,845) (17,597) (85,348) (46,266)
Other comprehensive loss        
Foreign currency translation loss (300) 22 (884) (187)
Comprehensive loss $ (67,145) $ (17,575) $ (86,232) $ (46,453)
Net loss per common share        
Basic (in dollars per share) $ (1.92) $ (0.55) $ (2.49) $ (1.55)
Diluted (in dollars per share) $ (1.92) $ (0.55) $ (2.49) $ (1.55)
Weighted average shares outstanding        
Basic (in shares) 34,769 31,857 34,344 29,818
Diluted (in shares) 34,769 31,857 34,344 29,818